Pharmaxis Ltd

PXS

Pharmaxis Ltd. is a pharmaceutical research company, which engages in the development and commercialization of healthcare products for fibrotic and inflammatory diseases. The company is headquartered in Frenchs Forest, New South Wales. The company went IPO on 2003-11-10. The firm has a productive drug discovery engine, drug candidates in clinical trials and two respiratory products approved in global markets. Its lead drug candidate, PXS-5505, is an orally taken drug that inhibits the lysyl oxidase family of enzymes. Its PXS-5505 is used for the treatment of the blood cancer myelofibrosis, which affects one in 500,000 people. PXS-5505 is also being investigated as a potential treatment for other cancers, such as liver and pancreatic cancer. The company also has two respiratory products: Bronchitol and Aridol. Bronchitol is used for the treatment of cystic fibrosis. Its other drugs in development include PXS-5382 (LOXL2 inhibitor), PXS-6302 (topical pan LOX inhibitor), PXS-4728 (SSAO inhibitor), PXS-4699 (dual SSAO/MAOB inhibitor) and PXS-5370 (dual SSAO/MPO inhibitor).

Rex Minerals Limited

RXM

Rex Minerals Ltd. engages in the exploration and development of mineral properties. The firm owns the Hillside Copper-Gold Project in South Australia and Hog Ranch Gold Property in Nevada, United States of America. The Hillside Copper-Gold Project is located approximately 12 kilometers south of the township of Ardrossan on the Yorke Peninsula and 3 kilometers north of Pine Point, South Australia. The Mineral Resource of the Hillside Copper Project consists of approximately 337 million tons of 0.6% copper, and 0.14 grams per ton (g/t) gold, equating to approximately 2.0 million tons of copper, 1.4 million ounces (Moz) of gold. The firm's Hog Ranch Property is located in Washoe County in north-west Nevada, approximately 45 kilometers from the California border and 91 kilometers from the Oregon border. The Hog Ranch Gold Property is focused on four project areas: Reno, Winnemucca, Elko and Las Vegas.

Kinatico Ltd

KYP

Kinatico Ltd. engages in the provision of screening and verification services. The company is headquartered in Perth, Western Australia. The company went IPO on 2015-09-08. Its pre-employment screening has a range of pre-employment checks for individuals looking to be job-ready and employers who need fast and accurate pre-hiring checks. Its verification services and workforce compliance management are engaged in verification, engagement, and ongoing compliance management of workforce. The company provides real-time workforce compliance management through its software-as-a- service (SaaS) RegTech solution Cited. Cited enables compliance monitoring spanning pre-employment to daily requirements related to geo-location, roles, and tasks applicable across a range of industries. The company also provides a range of pre-employment checks through its CVCheck solution. This is delivered through its technology platform, which provides employment screening and verification offerings.